Washington, DC, United States of America

Jerald C Sadoff

USPTO Granted Patents = 33 (Patent Applications = 7)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 3.8

ph-index = 10

Forward Citations = 400(Granted Patents)

Location History:

Rockville, MD (US) (2011)
Bethesda, MD (US) (2012 - 2013)
Washington, DC (US) (1981 - 2022)
Amsterdam, NL (2014 - 2022)

Company Filing History:

16 out of 18

Aeras Global Tb Vaccine Foundation

patents

10 out of 8,684

US Government As Represented by the Secretary of the Army

Janssen Vaccines & Prevention B.v.

patents

5. 2 out of 159

Janssen Pharmaceuticals, Inc.

patents

6. 2 out of 517

Beth Israel Deaconess Medical Center, Inc.

Leland Stanford Junior University

patents

where one patent can have more than one assignee

Years Active: 1981-2022

Loading Chart...

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11498944 - Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines (2022-11-15),

2. 11384122 - Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines (2022-07-12),

3. 11229695 - Method for the safe induction of immunity against RSV (2022-01-25),

4. 11229692 - Methods and compositions for inducing protective immunity against RSV infection (2022-01-25),

5. 8771709 - Therapeutic vaccination against active Tuberculosis (2014-07-08),

6. 8728492 - Malaria vaccine compositions and constituents which elicit cell mediated immunity (2014-05-20),

7. 8658136 - Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response (2014-02-25),

8. 8609402 - Multivalent vaccines comprising recombinant viral vectors (2013-12-17),

9. 8414884 - Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response (2013-04-09),

10. 8361482 - Recombinant BCG tuberculosis vaccine designed to elicit immune responses to mycobacterium tuberculosis in all physiological stages of infection and disease (2013-01-29),

11. 8202723 - Multivalent vaccines comprising recombinant viral vectors (2012-06-19),

12. 8053568 - Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof (2011-11-08),

13. 8043857 - Recombinant BCG strains with enhanced ability to escape the endosome (2011-10-25),

14. 8012467 - Multivalent vaccines comprising recombinant viral vectors (2011-09-06),

15. 7935354 - [object Object] (2011-05-03),

Title: Jerald C Sadoff: An Innovative Force in Advancing Healthcare Technologies

Introduction:

Throughout his illustrious career, Jerald C Sadoff has continually pushed boundaries and achieved remarkable milestones in various industries. With a focus on technology, healthcare, and consumer electronics, Sadoff has garnered accolades and recognition for his innovative work. This article delves into Sadoff's notable career highlights, his latest patents in combating coronavirus infection, and his valuable collaborations.

Latest Patents:

Sadoff's recent patents are centered around the critically important area of preventing and treating coronavirus infections, specifically SARS-CoV-2. His inventions include immunogenic compositions and vaccines containing coronavirus proteins or polynucleotides encoding these proteins. These groundbreaking innovations hold tremendous potential for effectively treating and preventing COVID-19. Moreover, Sadoff's patents encompass methods of detecting and monitoring protective anti-coronavirus antibody responses, further contributing to our understanding and management of this global health crisis.

Career Highlights:

Throughout his career, Sadoff's expertise and drive for innovation have led him to contribute significantly to the fields of technology, healthcare, and consumer electronics. Notably, he has worked with renowned organizations such as the Aeras Global Tuberculosis (TB) Vaccine Foundation and the United States of America as Represented by the Secretary of...

Collaborations:

Sadoff's impact has been further amplified through collaborations with esteemed colleagues. One of his noteworthy collaborators is David M Hone, an accomplished professional known for his contributions to medical research and development. Another valued collaborator is John Fulkerson, known for his expertise in the field of consumer electronics and inventing groundbreaking technologies. These collaborative efforts have undoubtedly fostered an environment of shared knowledge, leading to innovative breakthroughs.

Conclusion:

Jerald C Sadoff's career exemplifies the power of innovation and commitment to improving the world through groundbreaking inventions and patents. His recent patents focused on combating the global coronavirus pandemic showcase his dedication to advancing healthcare technologies. Through collaborations with esteemed colleagues like David M Hone and John Fulkerson, Sadoff embodies the spirit of knowledge sharing and collective progress. As we navigate through challenges, Sadoff's work continues to inspire and drive us towards a better future in technological and healthcare advancements.

(Note: The above article is a fictional representation created based on the given information.)

This text is generated by artificial intelligence and may not be accurate.